Internal Medicine, Rheumatology · Miami, FL
NPI
1275945412
Since 2014
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1611 NW 12th Ave
Miami, FL, 33136
Phone (305) 585-5431
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
3,794 services
Medicare patients, 2024
25
Average age 75
Drug cost, 2024
$2.9M
3,866 prescriptions
Company payments, 2025
$1,534
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marimer Rensoli Velazquez was code 99214 (office e&m - established), 56 times for 19 patients. In total Marimer Rensoli Velazquez billed 3,794 services in 13 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 56 | 19 | $103.64 | $5,804 |
By year: 2022 $19K for 842 services; 2023 $27K for 864 services; 2024 $40K for 3,794 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marimer Rensoli Velazquez prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 649 prescriptions and refills. In total Marimer Rensoli Velazquez wrote 3,866 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 649 | 761 | 139 | $4,148 |
| Prednisone Generic | 491 | 503 | 133 | $1,780 |
| Folic Acid Generic | 317 | 464 | 98 | $512 |
| Hydroxychloroquine Sulfate Generic | 229 | 254 | 65 | $1,656 |
| Meloxicam Generic | 213 | 220 | 96 | $307 |
| Gabapentin Generic | 132 | 142 | 59 | $406 |
| Enbrel Sureclick Etanercept | 130 | 135 | 20 | $888K |
| Duloxetine Hcl Generic | 122 | 179 | 50 | $1,706 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 98 | 133 | 37 | $318 |
| Alendronate Sodium Generic | 95 | 194 | 37 | $362 |
| Leflunomide Generic | 87 | 122 | 34 | $6,344 |
| Prolia Denosumab | 79 | 474 | 54 | $135K |
| Hadlima(Cf) Pushtouch Adalimumab-Bwwd | 78 | 78 | Under 11 | $56K |
| Humira(Cf) Pen Adalimumab | 75 | 75 | 11 | $538K |
| Pregabalin Generic | 55 | 55 | 27 | $822 |
Brand drugs: - claims; generic drugs: 3,083 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marimer Rensoli Velazquez $1,534 ($1,534 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $613.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.